Buy Rilutek (riluzole) Online For Sale
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Sanofi – Aventis Groupe
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Therapeutic Goods Administration (TGA)
Medicines & Healthcare products Regulatory Agency (MHRA)
It is a prescription drug used in the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord, resulting in muscle weakness, loss of motor function, and, ultimately, paralysis.
Rilutek is the brand name for the medication with the active ingredient riluzole. It is a prescription drug used in the treatment of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord, resulting in muscle weakness, loss of motor function, and, ultimately, paralysis. Riluzole is classified as a glutamate antagonist and works by modulating the release of glutamate, a neurotransmitter that is believed to play a role in the progression of ALS.
Here is a general description of Rilutek (riluzole):
Active Ingredient: Riluzole
Indication: Rilutek is primarily indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults. It is used to help slow the progression of the disease and prolong survival.
Mechanism of Action: Riluzole’s precise mechanism of action is not fully understood, but it is thought to work by inhibiting the release of glutamate, a neurotransmitter in the brain and spinal cord. Excess glutamate levels have been associated with the death of motor neurons in ALS. By reducing glutamate levels, Rilutek may help protect these neurons.
Administration: Rilutek is typically taken orally in the form of tablets. The specific dosage and administration schedule will be determined by a healthcare provider based on the patient’s individual needs.
Dosage: The recommended dosage may vary depending on the patient’s condition and response to treatment.
Efficacy: Clinical trials have shown that Rilutek can provide a modest benefit by extending the survival time and slowing the progression of ALS, although it is not a cure.
Common Side Effects: Common side effects may include nausea, weakness, dizziness, and elevated liver enzymes. These side effects should be discussed with a healthcare provider.
Precautions: Patients taking Rilutek should undergo regular monitoring, including liver function tests, as the medication can affect liver enzymes. Patients should inform their healthcare provider of any other medications they are taking and any underlying medical conditions.
Rilutek is not a cure for ALS, but it is one of the few medications approved for slowing the progression of the disease. It is important for individuals with ALS to discuss the potential benefits, risks, and side effects of Rilutek with their healthcare provider. It is typically prescribed as part of a comprehensive treatment plan for ALS that may also include physical therapy, assistive devices, and supportive care.
50 mg x 56 tablets